Nyxoah SA (NYXH) announced the FDA has issued an Approvable Letter regarding the Pre-Market Approval application for the Genio system. The Approvable Letter means that Nyxoah's application for marketing the device in the United States substantially meets the requirements of the Federal Food, Drug and Cosmetic Act and the FDAs PMA implementing regulations, and the FDA will approve the application subject to satisfactory completion of a manufacturing facilities, methods and controls review.
The company said the decision does not impact Genio's CE Mark or ongoing commercial activities in Europe.
For More Such Health News, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.